Ignite Creation Date:
2024-05-06 @ 7:06 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05891561
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2023-05-21
Brief Title:
Short-course Trastuzumab Pertuzumab With Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer
Sponsor:
Organization:
Shanghai Jiao Tong University School of Medicine